Simplex Trading
TNXP icon

Simplex Trading’s Tonix Pharmaceuticals TNXP Stock Holding History

Simplex Trading’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$722K Buy
56,600
+39,300
+227% +$507K ﹤0.01% 3163
2026
Q1 		$238K Buy
+17,300
New +$266K ﹤0.01% 4089
2025
Q4 		– Sell
-4,900
Closed -$118K – 10085
2025
Q3 		$118K Buy
+4,900
New +$182K ﹤0.01% 5550
2017
Q2 		– Hold
0
– -$1K – 6797
2017
Q1 		– Hold
0
– – – 5800
2016
Q4 		– Hold
0
– -$82K – 6529
2016
Q3 		– Hold
0
– – – 1695
2016
Q2 		– Hold
0
– – – 1929
2016
Q1 		– Hold
0
– – – 4532
2015
Q4 		– Hold
0
– – – 5011
2015
Q3 		– Hold
0
– – – 4013
2015
Q2 		– Hold
0
– – – 4804

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading's TNXP Position: Q2 2026 in Review

Simplex Trading sold out of Tonix Pharmaceuticals (TNXP) in Q2 2026, closing a stake of 5,108 shares — an estimated $65.9K sold.

Simplex Trading first reported a position in TNXP in Q1 2026 and held it in 1 quarter. The position peaked at $70.2K in Q1 2026. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Simplex Trading reported no remaining Tonix Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 5,108 Tonix Pharmaceuticals shares in Q2 2026, an estimated $65.9K.
  • Simplex Trading first reported a position in Tonix Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Simplex Trading's Tonix Pharmaceuticals position peaked at $70.2K in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.